CBAT vs. ARCT

Last updated Apr 1, 2026

Compare and contrast key facts about CBAK Energy Technology, Inc. (CBAT) and Arcturus Therapeutics Holdings Inc. (ARCT).

Performance

CBAT vs. ARCT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CBAK Energy Technology, Inc. (CBAT) and Arcturus Therapeutics Holdings Inc. (ARCT). The values are adjusted to include any dividend payments, if applicable.

CBAT vs. ARCT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
CBAT CBAK Energy Technology, Inc.	-0.96%	-11.16%	-10.48%	6.06%	-36.54%	-69.17%	1,165.00%
ARCT Arcturus Therapeutics Holdings Inc.	25.94%	-63.88%	-46.18%	85.91%	-54.17%	-14.68%	155.18%

Fundamentals

Market Cap CBAT : $73.82M ARCT : $211.42M
EPS CBAT : -$0.10 ARCT : $0.37
PS Ratio CBAT : 0.38 ARCT : 2.69
PB Ratio CBAT : 0.00 ARCT : 0.99
Total Revenue (TTM) CBAT : $195.19M ARCT : $78.24M
Gross Profit (TTM) CBAT : $18.42M ARCT : $97.08M
EBITDA (TTM) CBAT : -$18.44M ARCT : -$67.83M

Returns By Period

In the year-to-date period, CBAT achieves a -0.96% return, which is significantly lower than ARCT's 25.94% return.

CBAT

• 1D: 4.52%
• 1M: -18.91%
• YTD: -0.96%
• 6M: -7.57%
• 1Y: 3.76%
• 3Y*: -2.05%
• 5Y*: -30.95%
• 10Y*: -9.99%

ARCT

• 1D: 11.88%
• 1M: -6.20%
• YTD: 25.94%
• 6M: -58.11%
• 1Y: -27.10%
• 3Y*: -31.45%
• 5Y*: -28.22%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CBAT vs. ARCT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CBAT

CBAT Risk / Return Rank: 43
CBAT Sharpe Ratio Rank: 43
CBAT Sortino Ratio Rank: 44
CBAT Omega Ratio Rank: 42
CBAT Calmar Ratio Rank: 45
CBAT Martin Ratio Rank: 44

ARCT

ARCT Risk / Return Rank: 32
ARCT Sharpe Ratio Rank: 29
ARCT Sortino Ratio Rank: 37
ARCT Omega Ratio Rank: 37
ARCT Calmar Ratio Rank: 27
ARCT Martin Ratio Rank: 30

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CBAT vs. ARCT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CBAK Energy Technology, Inc. (CBAT) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CBAT	ARCT	Difference
Sharpe ratio Return per unit of total volatility	0.07	-0.28	+0.35
Sortino ratio Return per unit of downside risk	0.55	0.28	+0.27
Omega ratio Gain probability vs. loss probability	1.06	1.04	+0.02
Calmar ratio Return relative to maximum drawdown	0.13	-0.45	+0.58
Martin ratio Return relative to average drawdown	0.21	-0.73	+0.94
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CBAT vs. ARCT - Sharpe Ratio Comparison

The current CBAT Sharpe Ratio is 0.07, which is higher than the ARCT Sharpe Ratio of -0.28. The chart below compares the historical Sharpe Ratios of CBAT and ARCT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CBAT	ARCT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.07	-0.28	+0.35
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.44	-0.31	-0.14
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.10	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.00	-0.12	+0.12

Correlation

The correlation between CBAT and ARCT is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CBAT vs. ARCT - Dividend Comparison

Neither CBAT nor ARCT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

CBAT vs. ARCT - Drawdown Comparison

The maximum CBAT drawdown since its inception was -99.49%, roughly equal to the maximum ARCT drawdown of -95.23%. Use the drawdown chart below to compare losses from any high point for CBAT and ARCT.

Drawdown Indicators

	CBAT	ARCT	Difference
Max Drawdown Largest peak-to-trough decline	-99.49%	-95.23%	-4.26%
Max Drawdown (1Y) Largest decline over 1 year	-36.04%	-74.53%	+38.49%
Max Drawdown (5Y) Largest decline over 5 years	-87.85%	-89.87%	+2.02%
Max Drawdown (10Y) Largest decline over 10 years	-94.34%	—	—
Current Drawdown Current decline from peak	-98.68%	-93.76%	-4.92%
Average Drawdown Average peak-to-trough decline	-79.31%	-72.38%	-6.93%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.08%	45.45%	-23.37%

Volatility

CBAT vs. ARCT - Volatility Comparison

The current volatility for CBAK Energy Technology, Inc. (CBAT) is 15.14%, while Arcturus Therapeutics Holdings Inc. (ARCT) has a volatility of 20.46%. This indicates that CBAT experiences smaller price fluctuations and is considered to be less risky than ARCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CBAT	ARCT	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.14%	20.46%	-5.32%
Volatility (6M) Calculated over the trailing 6-month period	38.65%	84.29%	-45.64%
Volatility (1Y) Calculated over the trailing 1-year period	57.07%	95.88%	-38.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.86%	92.15%	-22.29%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	98.65%	103.31%	-4.66%

Financials